Meta is doubling down on smart glasses as its breakthrough AI hardware product, launching two new prescription models at $499 each. The company unveiled the Ray-Ban Meta Blayzer Optics and Ray-Ban Meta Scriber Optics on Tuesday, expanding its offerings to prescription eyewear users. These glasses will be available for pre-order in the U.S. starting at $499 and roll out to optical retailers on April 14 .

While much of the tech industry chases abstract AI breakthroughs, Meta has found something more tangible: a product people actually want to wear. The company now controls roughly 76.1% of the global smart glasses market, according to International Data Corporation research . That's not a niche product; that's market dominance.

Why Are Prescription Smart Glasses Such a Big Deal?

CEO Mark Zuckerberg identified the opportunity early. "Billions of people wear glasses or contacts for vision correction," he noted in January, recognizing that the addressable market for smart eyewear extends far beyond tech enthusiasts . Most smart glasses launched to date have ignored this massive population, but Meta saw the gap and filled it.

The new prescription models feature practical design improvements that make them genuinely wearable for everyday use. These include overextension hinges, interchangeable nose pads, and optician-adjustable temple tips to accommodate different face shapes . These aren't flashy features, but they're the kind of thoughtful engineering that separates products people actually use from expensive novelties.

The timing matters too. Global smart glasses shipments reached 9.6 million units last year, with Meta accounting for the vast majority. Industry analysts expect that number to grow to 13.4 million units in 2026, signaling real momentum in the category .

How to Choose the Right Meta Smart Glasses for Your Needs

• Display vs. Non-Display: Meta's Ray-Ban Meta Display glasses launched last year at $799 with a built-in screen for reading messages and following navigation. The new prescription models at $499 focus on core AI features without the display, making them more affordable and lighter to wear.
• Prescription Lens Options: The Display model can be ordered with prescription lenses for an additional $200, while the new Blayzer Optics and Scriber Optics come with prescription capabilities built in at the $499 price point.
• Customization Features: Both new models offer adjustable temple tips, interchangeable nose pads, and overextension hinges, allowing optical professionals to tailor the fit to your unique face shape and comfort preferences.

Meta's investment in smart glasses reflects a broader strategy. The company plans to invest hundreds of billions of dollars pursuing what it calls "personal superintelligence," where advanced gadgets bring AI benefits directly to individual users . Smart glasses are the physical embodiment of that vision.

The competition is heating up, but Meta's head start is substantial. Snap has established an independent subsidiary for its augmented reality smart glasses and is preparing a consumer launch. Google partnered with Warby Parker to develop AI glasses . Yet Meta's 76% market share suggests the company has already won the early race.

The stock market noticed. Meta shares rose nearly 4% on the announcement, though the company's stock has fallen around 19% so far this year, reflecting broader investor concerns about the company's massive AI spending . These new glasses suggest that spending is translating into real products people want.

The prescription glasses launch reveals something important about AI's near-term future. The most impactful AI products won't necessarily be the ones with the biggest models or the most impressive benchmarks. They'll be the ones that solve real problems for billions of people. For Meta, that means recognizing that most people who need glasses actually need glasses, and building AI hardware that works for them.